Ubiquitin-dependent proteolysis: its role in human diseases and the design of therapeutic strategies
- 16 September 2002
- journal article
- review article
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 77 (1-2) , 44-56
- https://doi.org/10.1016/s1096-7192(02)00146-4
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Drug-induced ubiquitylation and degradation of ErbB receptor tyrosine kinases: implications for cancer therapyThe EMBO Journal, 2002
- Structure of the Cul1–Rbx1–Skp1–F boxSkp2 SCF ubiquitin ligase complexNature, 2002
- Solution structure of the PHD domain from the KAP-1 corepressor: structural determinants for PHD, RING and LIM zinc-binding domainsThe EMBO Journal, 2001
- Activation of the IκB Kinase Complex by TRAF6 Requires a Dimeric Ubiquitin-Conjugating Enzyme Complex and a Unique Polyubiquitin ChainPublished by Elsevier ,2000
- Targeted disruption of Skp2 results in accumulation of cyclin E and p27Kip1, polyploidy and centrosome overduplicationThe EMBO Journal, 2000
- The SCFbeta -TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in Ikappa Balpha and beta -catenin and stimulates Ikappa Balpha ubiquitination in vitroGenes & Development, 1999
- AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 1998
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997
- UBE3A/E6-AP mutations cause Angelman syndromeNature Genetics, 1997
- The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53Cell, 1993